Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroid-induced osteoporosis

J D Adachi1

  • 1Department of Medicine, St. Joseph's Hospital--McMaster University, Ontario, Canada.

The American Journal of the Medical Sciences
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing types and circumstances of fractures in the Canadian Multicentre Osteoporosis Study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group.

Archives of osteoporosis·2022
Same author

Incremental costs of fragility fractures: a population-based matched -cohort study from Ontario, Canada.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Exploring changes in bone mass in individuals with a chronic spinal cord injury.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

A scorecard for osteoporosis in Canada and seven Canadian provinces.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of Acute Myeloid Leukemia Patients Admitted to the Intensive Care Unit within 100 days of Allogeneic Hematopoietic Stem Cell Transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

This article explains how corticosteroids cause osteoporosis and reviews current treatment options based on the underlying pathophysiology. It provides a literature review for managing this condition.

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Pharmacology

Background:

  • Corticosteroids are widely used medications with significant side effects.
  • Corticosteroid-induced osteoporosis (CIOP) is a common and serious complication.
  • Understanding the mechanisms of CIOP is crucial for effective management.

Purpose of the Study:

  • To outline the pathophysiology of corticosteroid-induced osteoporosis.
  • To review current and emerging treatment strategies for CIOP.
  • To provide clinicians with evidence-based recommendations for managing CIOP.

Main Methods:

  • Literature review of preclinical and clinical studies on CIOP.
  • Analysis of the molecular and cellular mechanisms underlying CIOP.
  • Synthesis of data on the efficacy and safety of various therapeutic interventions.

Related Experiment Videos

Main Results:

  • Corticosteroids disrupt bone remodeling by inhibiting osteoblast function and promoting osteoclast activity.
  • Key pathways involved include suppression of Wnt/β-catenin signaling and enhancement of apoptosis in osteoblasts.
  • Several therapeutic agents, including bisphosphonates and teriparatide, show efficacy in preventing or treating CIOP.

Conclusions:

  • Corticosteroid-induced osteoporosis is a multifactorial condition driven by complex pathophysiological mechanisms.
  • Early diagnosis and prompt intervention with appropriate pharmacotherapy are essential for mitigating bone loss and fracture risk.
  • Further research is needed to optimize treatment strategies and improve long-term outcomes for patients on corticosteroid therapy.